StockData
Viridian Therapeutics, Inc.DE logo

Viridian Therapeutics, Inc.DE (VRDN) stock

VRDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30260% above fair value
$29.96−1.48 (-4.71%)

Close on Nov 20, 2026Market cap $3.39BP/E –Yield –

Viridian Therapeutics, Inc.DE market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Viridian Therapeutics, Inc.DE's market cap was $3.54B on Nov 11, 2026, against $2.63B a year earlier. Over the last 5 years it ranged from $276.80M to $3.54B, with a median of $1.10B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.54B+38.3%
2025Dec 31, 2025$2.56B+68.6%
2024Dec 31, 2024$1.52B+59.5%
2023Dec 29, 2023$951.81M-19.0%
2022Dec 30, 2022$1.18B+206.9%
2021Dec 31, 2021$383.08M+512.0%
2020Dec 31, 2020$62.59M+318.3%
2019Dec 31, 2019$14.96M-84.0%
2018Dec 31, 2018$93.42M-59.1%
2017Dec 29, 2017$228.27M+6234.0%
2016Dec 30, 2016$3.60M-54.7%
2015Dec 31, 2015$7.96M+976.6%
2014Dec 31, 2014$738.95K–

More Viridian Therapeutics, Inc.DE figures

See a number that looks wrong?